Moonshot AI’s $20 billion valuation confirms it as one of the fastest-growing AI funding journeys in China.

      Meituan Dragon Ball is spearheading a $2 billion funding round for the Beijing-based developer of the Kimi chatbot, Moonshot AI, with participation from China Mobile and CITIC Private Equity Funds. This new valuation is approximately seven times the amount that Moonshot was valued at sixteen months ago.

      According to a report from Bloomberg on Wednesday, Moonshot AI is finalizing a $2 billion funding round that will result in a post-money valuation exceeding $20 billion. The round is being led by Meituan’s Dragon Ball investment segment, alongside contributions from China Mobile, CITIC Private Equity Funds, and other entities. Meituan Dragon Ball is investing more than $200 million alone.

      This marks the third significant valuation increase for Moonshot in less than two years. In February 2024, the initial funding round led by Alibaba valued the company at $2.5 billion post-money after a $1 billion raise. A subsequent round in December 2024 raised the valuation to $3 billion, although a brief legal dispute with five early investors momentarily halted the company's progress. The new valuation of $20 billion represents approximately seven times the December 2024 figure, showcasing a quicker growth trajectory than any other Chinese AI lab in this cycle.

      Founded in March 2023 by Yang Zhilin, Zhou Xinyu, and Wu Yuxin—three former classmates from Tsinghua University—Moonshot has gained traction rapidly. Yang previously worked at Carnegie Mellon and Meta’s FAIR research lab, and he holds a doctorate in machine learning. The Kimi product line, aimed at consumers, has served as the primary commercial platform for Moonshot's foundational models. The annual recurring revenue for Kimi has surged from $100 million at the beginning of March 2026 to over $200 million by the end of April, reflecting a doubling in just two months, which the pricing of the new round is reportedly linked to.

      The investment structure led by Meituan is noteworthy. Meituan Dragon Ball, which is the strategic investment arm of the food and services platform, has been quietly acquiring stakes in Chinese AI over the past 18 months. China Mobile, a state-owned telecom operator, offers a different strategic alignment, facilitating access to distribution and infrastructure that is favorable to state interests. CITIC Private Equity Funds, the third participant, is among the largest private equity firms in China. Since its launch, Kimi K2 has effectively competed against international offerings concerning coding and tool-use benchmarks.

      Moonshot has now secured over $3.9 billion in funding over the past six months, making it the most heavily funded Chinese LLM startup of this cycle, and it is nearing DeepSeek’s valuation discussions of $45 billion reported earlier this month. Both companies are key players in the Chinese frontier-AI landscape but have notably different strategies: DeepSeek emphasizes research output and open-source contributions, whereas Moonshot focuses on consumer products and generating commercial revenue. The company is reportedly gearing up for a public listing.

      There are some caveats worth mentioning. The funding round has not been formally closed, as indicated by Tracxn’s company profile, and the specific terms of Meituan Dragon Ball’s investment have not been disclosed. The $20 billion valuation is based on reports from Bloomberg, corroborated by sources like BigGo and 36Kr, but has not been officially confirmed by Moonshot. The strategic implications of involving China Mobile at this scale are yet to be assessed.

      The broader context aligns with the Chinese AI funding landscape of 2026, where strategic, state-aligned capital, large corporate investment arms, and major private equity firms are converging on a limited number of frontier-AI labs at valuations that would have previously been considered speculative just six months ago. The Moonshot funding round reinforces this trend. While the revenue trajectory of the Kimi product supports its commercial viability, it remains to be seen whether the entire Chinese AI funding cycle can sustain such high valuations, or if there will be a contraction when faced with public-market scrutiny in the future.